Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease
Serum calprotectin levels can be used to accurately predict sarcopenia in patients with COPD, and the calprotectin inhibitor paquinimod is a potential treatment for CS-induced skeletal muscle dysfunction.
Authors
- Jiaye Li (ORCID: https://orcid.org/0000-0002-5071-5325)
- Xiaoming Zhou (ORCID: https://orcid.org/0000-0003-1398-5382)
- yanxia li
- Gang Hou (ORCID: https://orcid.org/0000-0003-3438-1764)
- Weidong Xu (ORCID: https://orcid.org/0000-0001-6477-9461)
- Chang Chun Li
- Mingming Deng
- Yan Yin
- Liwei Liao
- Zilin Wang
Institutions
- Dalian Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
- First Hospital of China Medical University (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Fu Wai Hospital (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Cachexia Sarcopenia and Muscle
- Published
- 2026-01-25
- DOI
- https://doi.org/10.1002/jcsm.70196
- Citations
- 1
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 22.24